Benefit of 2D-strain surveillance in improving cardiovascular outcomes in cancer patients undergoing cardiotoxic chemotherapy [ 2017 - 2022 ]

Research Grant

Researchers: Prof Thomas Marwick (Principal investigator) ,  A/Pr Andre La Gerche ,  A/Pr Peter Mollee ,  A/Pr Sherene Loi ,  Dr Constantine Tam
View all 10 related researchers

Brief description Cancer survivors are susceptible to heart failure (HF) caused by heart muscle damage from chemotherapy. The current testing for this problem is based on a measure that cannot identify minor changes of cardiac function. Cardiac strain is a sensitive new marker of cardiac function which is predictive of overt dysfunction & HF. This study seeks to identify whether strain can be used to assign treatments that lead to improved cardiac function and are eventually associated with a reduction in HF.

Funding Amount $AUD 2,455,981.21

Funding Scheme Project Grants

Notes Standard Project Grant